Aytu BioPharma: Q3 Earnings Insights

Aytu BioPharma AYTU reported its Q3 earnings results on Thursday, May 11, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Aytu BioPharma missed estimated earnings by 206.35%, reporting an EPS of $-1.93 versus an estimate of $-0.63.

Revenue was down $1.47 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.55 which was followed by a 5.78% drop in the share price the next day.

Here's a look at Aytu BioPharma's past performance:

Quarter Q2 2023 Q1 2023 Q4 2022 Q3 2022
EPS Estimate -1.60 -3.6 -7.4 -8.2
EPS Actual -2.15 -1.2 -9.8 -5.4
Revenue Estimate 26.40M 24.30M 25.50M 24.80M
Revenue Actual 26.28M 27.66M 27.45M 24.20M

To track all earnings releases for Aytu BioPharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!